Revenue: The sum of all revenue fields included for a company's operating activities.
Neurocrine Biosciences, Inc. (NBIX) had Revenue of $2.36B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$2.36B |
$341.30M |
|
$34.00M |
|
$2.32B |
|
$1.78B |
|
$570.50M |
|
$-84.50M |
|
$486.00M |
|
$523.10M |
|
$341.30M |
|
$341.30M |
|
$341.30M |
|
$389.45M |
|
$570.50M |
|
$571.40M |
|
100.40M |
|
103.70M |
|
$3.40 |
|
$3.29 |
|
| Balance Sheet Financials | |
$1.72B |
|
$82.60M |
|
$1.99B |
|
$3.72B |
|
$507.70M |
|
-- |
|
$621.30M |
|
$1.13B |
|
$2.59B |
|
$2.55B |
|
$2.59B |
|
99.40M |
|
| Cash Flow Statement Financials | |
$595.40M |
|
$-126.80M |
|
$-486.70M |
|
$259.10M |
|
$241.00M |
|
$-18.10M |
|
$195.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.56% |
|
24.22% |
|
24.22% |
|
24.26% |
|
20.63% |
|
14.49% |
|
$557.20M |
|
-- |
|
-- |
|
-- |
|
0.63 |
|
0.59 |
|
4.92 |
|
74.25 |
|
13.18% |
|
13.37% |
|
9.18% |
|
13.18% |
|
$26.05 |
|
$5.37 |
|
$5.74 |
|